Abstract
We present the case of a woman (age: 64 years) with acute thrombotic microangiopathy due to severe acquired ADAMTS-13 (von Willebrand factor-cleaving protease) deficiency. She was successfully treated with plasma exchange therapy and glucocorticosteroids. She relapsed seven months later, and splenectomy led to lasting remission. Pathomechanisms of thrombotic thrombocytopenic purpura, especially the role of ADAMTS-13, are discussed and therapeutic measures outlined.
MeSH terms
-
ADAM Proteins
-
ADAMTS13 Protein
-
Anemia, Hemolytic / blood
-
Anemia, Hemolytic / etiology*
-
Anemia, Hemolytic / therapy
-
Female
-
Humans
-
Kidney Diseases / blood
-
Kidney Diseases / etiology
-
Kidney Diseases / therapy
-
Metalloendopeptidases / deficiency*
-
Microcirculation / pathology
-
Middle Aged
-
Plasma Exchange
-
Purpura, Thrombotic Thrombocytopenic / blood
-
Purpura, Thrombotic Thrombocytopenic / etiology*
-
Purpura, Thrombotic Thrombocytopenic / therapy
-
Thrombosis / blood
-
Thrombosis / etiology
-
Thrombosis / therapy
Substances
-
ADAM Proteins
-
Metalloendopeptidases
-
ADAMTS13 Protein
-
ADAMTS13 protein, human